A Companion Animal Genomics & DNA Testing Market Forecasts to 2032 – Global Analysis By Test Type (Breed Identification Testing, Genetic Health Risk Testing, Disease Screening & Carrier Testing, Trait & Ancestry Testing and Wellness & Nutrition Genomics)
Description
According to Stratistics MRC, the Global Companion Animal Genomics & DNA Testing Market is accounted for $864.55 million in 2025 and is expected to reach $1,510.75 million by 2032 growing at a CAGR of 8.3% during the forecast period. Companion Animal Genomics & DNA Testing refers to the scientific analysis of genetic material in pets such as dogs and cats to understand their breed composition, inherited traits, health risks, and ancestry. Built on decades of classical genetics and modern molecular biology, it applies advanced DNA sequencing and bioinformatics to support preventive healthcare, personalized nutrition, responsible breeding, and disease management. This field enables veterinarians, breeders, and pet owners to anticipate hereditary conditions, optimize wellness plans, and improve quality of life. As technology advances, it is shaping the future of precision veterinary care while preserving the time-honored bond between humans and their companion animals.
Market Dynamics:
Driver:
Rising Pet Ownership & Humanization of Pets
Rising pet ownership, coupled with the deepening emotional bond between humans and their companion animals, is a major growth driver for the market. Pets are increasingly viewed as family members, prompting owners to invest in advanced healthcare, wellness monitoring, and preventive diagnostics. Genetic testing helps owners understand breed traits, behavioral tendencies, and inherited health risks early, enabling proactive care. This long-standing love for animals, now reinforced by modern science, continues to fuel sustained demand for genomics-based pet solutions.
Restraint:
High Cost of Genetic Testing
The high cost associated with companion animal genetic testing acts as a notable market restraint, particularly in price-sensitive regions. Advanced DNA sequencing, bioinformatics analysis, and laboratory infrastructure significantly increase testing expenses. For many pet owners, especially in emerging economies, these costs limit adoption despite growing awareness. Additionally, premium pricing restricts routine or repeat testing, slowing market penetration. Until testing becomes more affordable, cost barriers will continue to challenge widespread market expansion.
Opportunity:
Advances in Technologies
Rapid advancements in genomic technologies present a strong opportunity for market growth. Innovations in next-generation sequencing, SNP genotyping, AI-driven analytics, and cloud-based bioinformatics are improving accuracy while reducing turnaround time. These technological improvements are also lowering operational costs, enabling broader accessibility. As testing platforms become more efficient and user-friendly, companies can expand offerings beyond breed identification to disease prediction, nutrition planning, and personalized care, opening new revenue streams across veterinary and consumer markets.
Threat:
Regulatory & Ethical Challenges
Regulatory and ethical challenges pose a potential threat to the market. Variations in genetic data protection laws, veterinary regulations, and testing standards across regions complicate commercialization. Ethical concerns surrounding data ownership, genetic discrimination in breeding, and misuse of pet DNA information further intensify scrutiny. Companies must navigate evolving compliance frameworks while maintaining transparency and trust. Failure to address these issues could slow approvals, and impact long-term market credibility.
Covid-19 Impact:
The COVID-19 pandemic had a mixed impact on the companion animal genomics and DNA testing market. While supply chain disruptions and temporary laboratory closures slowed operations initially, lockdowns triggered a surge in pet adoption globally. Increased time spent with pets heightened owner awareness of pet health and wellness, accelerating interest in genetic testing. Post-pandemic recovery has strengthened demand, with digital ordering, at-home sample kits, and tele-veterinary integration supporting market resilience and long-term growth.
The breed identification testing segment is expected to be the largest during the forecast period
The breed identification testing segment is expected to account for the largest market share during the forecast period, due to strong consumer demand and widespread awareness. Pet owners increasingly seek insights into breed composition to better understand behavior, size expectations, and potential health risks. This segment benefits from direct-to-consumer test kits, simplified reporting, and strong marketing by leading players. Its affordability and immediate, tangible value make breed identification the most widely adopted entry point into companion animal genomics.
The SNP genotyping segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the SNP genotyping segment is predicted to witness the highest growth rate, due to its superior accuracy and expanding clinical applications. SNP-based testing enables precise detection of genetic variations linked to inherited diseases, traits, and drug responses. Growing adoption by veterinary clinics and breeders for advanced diagnostics and preventive care supports rapid growth. As costs decline and data interpretation improves, SNP genotyping is emerging as the backbone technology for precision veterinary medicine.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, urbanization, and expanding middle-class populations. Increasing awareness of pet healthcare, coupled with growing veterinary infrastructure and digital pet services, supports market dominance. Countries such as China, Japan, and Australia are witnessing rapid adoption of genetic testing solutions. Strong growth in companion animal spending and improving access to advanced diagnostics underpin the region’s leadership.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, high pet healthcare expenditure, and early adoption of genomic technologies. Strong presence of key market players, widespread availability of direct-to-consumer testing kits, and high awareness among pet owners accelerate growth. Additionally, ongoing research, innovation, and integration of genomics into routine veterinary practice position North America as the fastest-growing regional market.
Key players in the market
Some of the key players in Companion Animal Genomics & DNA Testing Market include Neogen Corporation, UC Davis Veterinary Genetics Laboratory, Zoetis Inc., ZOOGEN, IDEXX Laboratories, Generatio GmbH, Thermo Fisher Scientific, VetGen LLC, Mars Petcare, Eurofins Scientific, Embark Veterinary, Antech Diagnostics, Basepaws, Animal Genetics Inc. and Orivet Genetic Pet Care.
Key Developments:
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team’s Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Test Types Covered:
• Breed Identification Testing
• Genetic Health Risk Testing
• Disease Screening & Carrier Testing
• Trait & Ancestry Testing
• Wellness & Nutrition Genomics
Animal Types Covered:
• Dogs
• Cats
• Horses
• Other Animal Types
Distribution Channels Covered:
• Direct-to-Consumer (DTC)
• Veterinary Referral Testing
• Online Platforms
• Diagnostic Laboratories
Technologies Covered:
• PCR-based Testing
• Next-Generation Sequencing (NGS)
• SNP Genotyping
• Microarray Technology
• Whole Genome Sequencing
Applications Covered:
• Disease Prediction & Prevention
• Personalized Treatment Planning
• Breeding Management
• Behavioral & Trait Analysis
End Users Covered:
• Veterinary Clinics & Hospitals
• Pet Owners
• Research Institutions
• Breeders & Kennel Clubs
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Market Dynamics:
Driver:
Rising Pet Ownership & Humanization of Pets
Rising pet ownership, coupled with the deepening emotional bond between humans and their companion animals, is a major growth driver for the market. Pets are increasingly viewed as family members, prompting owners to invest in advanced healthcare, wellness monitoring, and preventive diagnostics. Genetic testing helps owners understand breed traits, behavioral tendencies, and inherited health risks early, enabling proactive care. This long-standing love for animals, now reinforced by modern science, continues to fuel sustained demand for genomics-based pet solutions.
Restraint:
High Cost of Genetic Testing
The high cost associated with companion animal genetic testing acts as a notable market restraint, particularly in price-sensitive regions. Advanced DNA sequencing, bioinformatics analysis, and laboratory infrastructure significantly increase testing expenses. For many pet owners, especially in emerging economies, these costs limit adoption despite growing awareness. Additionally, premium pricing restricts routine or repeat testing, slowing market penetration. Until testing becomes more affordable, cost barriers will continue to challenge widespread market expansion.
Opportunity:
Advances in Technologies
Rapid advancements in genomic technologies present a strong opportunity for market growth. Innovations in next-generation sequencing, SNP genotyping, AI-driven analytics, and cloud-based bioinformatics are improving accuracy while reducing turnaround time. These technological improvements are also lowering operational costs, enabling broader accessibility. As testing platforms become more efficient and user-friendly, companies can expand offerings beyond breed identification to disease prediction, nutrition planning, and personalized care, opening new revenue streams across veterinary and consumer markets.
Threat:
Regulatory & Ethical Challenges
Regulatory and ethical challenges pose a potential threat to the market. Variations in genetic data protection laws, veterinary regulations, and testing standards across regions complicate commercialization. Ethical concerns surrounding data ownership, genetic discrimination in breeding, and misuse of pet DNA information further intensify scrutiny. Companies must navigate evolving compliance frameworks while maintaining transparency and trust. Failure to address these issues could slow approvals, and impact long-term market credibility.
Covid-19 Impact:
The COVID-19 pandemic had a mixed impact on the companion animal genomics and DNA testing market. While supply chain disruptions and temporary laboratory closures slowed operations initially, lockdowns triggered a surge in pet adoption globally. Increased time spent with pets heightened owner awareness of pet health and wellness, accelerating interest in genetic testing. Post-pandemic recovery has strengthened demand, with digital ordering, at-home sample kits, and tele-veterinary integration supporting market resilience and long-term growth.
The breed identification testing segment is expected to be the largest during the forecast period
The breed identification testing segment is expected to account for the largest market share during the forecast period, due to strong consumer demand and widespread awareness. Pet owners increasingly seek insights into breed composition to better understand behavior, size expectations, and potential health risks. This segment benefits from direct-to-consumer test kits, simplified reporting, and strong marketing by leading players. Its affordability and immediate, tangible value make breed identification the most widely adopted entry point into companion animal genomics.
The SNP genotyping segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the SNP genotyping segment is predicted to witness the highest growth rate, due to its superior accuracy and expanding clinical applications. SNP-based testing enables precise detection of genetic variations linked to inherited diseases, traits, and drug responses. Growing adoption by veterinary clinics and breeders for advanced diagnostics and preventive care supports rapid growth. As costs decline and data interpretation improves, SNP genotyping is emerging as the backbone technology for precision veterinary medicine.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, urbanization, and expanding middle-class populations. Increasing awareness of pet healthcare, coupled with growing veterinary infrastructure and digital pet services, supports market dominance. Countries such as China, Japan, and Australia are witnessing rapid adoption of genetic testing solutions. Strong growth in companion animal spending and improving access to advanced diagnostics underpin the region’s leadership.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, high pet healthcare expenditure, and early adoption of genomic technologies. Strong presence of key market players, widespread availability of direct-to-consumer testing kits, and high awareness among pet owners accelerate growth. Additionally, ongoing research, innovation, and integration of genomics into routine veterinary practice position North America as the fastest-growing regional market.
Key players in the market
Some of the key players in Companion Animal Genomics & DNA Testing Market include Neogen Corporation, UC Davis Veterinary Genetics Laboratory, Zoetis Inc., ZOOGEN, IDEXX Laboratories, Generatio GmbH, Thermo Fisher Scientific, VetGen LLC, Mars Petcare, Eurofins Scientific, Embark Veterinary, Antech Diagnostics, Basepaws, Animal Genetics Inc. and Orivet Genetic Pet Care.
Key Developments:
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team’s Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Test Types Covered:
• Breed Identification Testing
• Genetic Health Risk Testing
• Disease Screening & Carrier Testing
• Trait & Ancestry Testing
• Wellness & Nutrition Genomics
Animal Types Covered:
• Dogs
• Cats
• Horses
• Other Animal Types
Distribution Channels Covered:
• Direct-to-Consumer (DTC)
• Veterinary Referral Testing
• Online Platforms
• Diagnostic Laboratories
Technologies Covered:
• PCR-based Testing
• Next-Generation Sequencing (NGS)
• SNP Genotyping
• Microarray Technology
• Whole Genome Sequencing
Applications Covered:
• Disease Prediction & Prevention
• Personalized Treatment Planning
• Breeding Management
• Behavioral & Trait Analysis
End Users Covered:
• Veterinary Clinics & Hospitals
• Pet Owners
• Research Institutions
• Breeders & Kennel Clubs
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Companion Animal Genomics & DNA Testing Market, By Test Type
- 5.1 Introduction
- 5.2 Breed Identification Testing
- 5.3 Genetic Health Risk Testing
- 5.4 Disease Screening & Carrier Testing
- 5.5 Trait & Ancestry Testing
- 5.6 Wellness & Nutrition Genomics
- 6 Global Companion Animal Genomics & DNA Testing Market, By Animal Type
- 6.1 Introduction
- 6.2 Dogs
- 6.3 Cats
- 6.4 Horses
- 6.5 Other Animal Types
- 7 Global Companion Animal Genomics & DNA Testing Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Direct-to-Consumer (DTC)
- 7.3 Veterinary Referral Testing
- 7.4 Online Platforms
- 7.5 Diagnostic Laboratories
- 8 Global Companion Animal Genomics & DNA Testing Market, By Technology
- 8.1 Introduction
- 8.2 PCR-based Testing
- 8.3 Next-Generation Sequencing (NGS)
- 8.4 SNP Genotyping
- 8.5 Microarray Technology
- 8.6 Whole Genome Sequencing
- 9 Global Companion Animal Genomics & DNA Testing Market, By Application
- 9.1 Introduction
- 9.2 Disease Prediction & Prevention
- 9.3 Personalized Treatment Planning
- 9.4 Breeding Management
- 9.5 Behavioral & Trait Analysis
- 10 Global Companion Animal Genomics & DNA Testing Market, By End User
- 10.1 Introduction
- 10.2 Veterinary Clinics & Hospitals
- 10.3 Pet Owners
- 10.4 Research Institutions
- 10.5 Breeders & Kennel Clubs
- 11 Global Companion Animal Genomics & DNA Testing Market, By Geography
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
- 11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
- 11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa
- 12 Key Developments
- 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 12.2 Acquisitions & Mergers
- 12.3 New Product Launch
- 12.4 Expansions
- 12.5 Other Key Strategies
- 13 Company Profiling
- 13.1 Neogen Corporation
- 13.2 UC Davis Veterinary Genetics Laboratory
- 13.3 Zoetis Inc.
- 13.4 ZOOGEN
- 13.5 IDEXX Laboratories
- 13.6 Generatio GmbH
- 13.7 Thermo Fisher Scientific
- 13.8 VetGen LLC
- 13.9 Mars Petcare
- 13.10 Eurofins Scientific
- 13.11 Embark Veterinary
- 13.12 Antech Diagnostics
- 13.13 Basepaws
- 13.14 Animal Genetics Inc.
- 13.15 Orivet Genetic Pet Care
- List of Tables
- Table 1 Global Companion Animal Genomics & DNA Testing Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Companion Animal Genomics & DNA Testing Market Outlook, By Test Type (2024-2032) ($MN)
- Table 3 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breed Identification Testing (2024-2032) ($MN)
- Table 4 Global Companion Animal Genomics & DNA Testing Market Outlook, By Genetic Health Risk Testing (2024-2032) ($MN)
- Table 5 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Screening & Carrier Testing (2024-2032) ($MN)
- Table 6 Global Companion Animal Genomics & DNA Testing Market Outlook, By Trait & Ancestry Testing (2024-2032) ($MN)
- Table 7 Global Companion Animal Genomics & DNA Testing Market Outlook, By Wellness & Nutrition Genomics (2024-2032) ($MN)
- Table 8 Global Companion Animal Genomics & DNA Testing Market Outlook, By Animal Type (2024-2032) ($MN)
- Table 9 Global Companion Animal Genomics & DNA Testing Market Outlook, By Dogs (2024-2032) ($MN)
- Table 10 Global Companion Animal Genomics & DNA Testing Market Outlook, By Cats (2024-2032) ($MN)
- Table 11 Global Companion Animal Genomics & DNA Testing Market Outlook, By Horses (2024-2032) ($MN)
- Table 12 Global Companion Animal Genomics & DNA Testing Market Outlook, By Other Animal Types (2024-2032) ($MN)
- Table 13 Global Companion Animal Genomics & DNA Testing Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 14 Global Companion Animal Genomics & DNA Testing Market Outlook, By Direct-to-Consumer (DTC) (2024-2032) ($MN)
- Table 15 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Referral Testing (2024-2032) ($MN)
- Table 16 Global Companion Animal Genomics & DNA Testing Market Outlook, By Online Platforms (2024-2032) ($MN)
- Table 17 Global Companion Animal Genomics & DNA Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
- Table 18 Global Companion Animal Genomics & DNA Testing Market Outlook, By Technology (2024-2032) ($MN)
- Table 19 Global Companion Animal Genomics & DNA Testing Market Outlook, By PCR-based Testing (2024-2032) ($MN)
- Table 20 Global Companion Animal Genomics & DNA Testing Market Outlook, By Next-Generation Sequencing (NGS) (2024-2032) ($MN)
- Table 21 Global Companion Animal Genomics & DNA Testing Market Outlook, By SNP Genotyping (2024-2032) ($MN)
- Table 22 Global Companion Animal Genomics & DNA Testing Market Outlook, By Microarray Technology (2024-2032) ($MN)
- Table 23 Global Companion Animal Genomics & DNA Testing Market Outlook, By Whole Genome Sequencing (2024-2032) ($MN)
- Table 24 Global Companion Animal Genomics & DNA Testing Market Outlook, By Application (2024-2032) ($MN)
- Table 25 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Prediction & Prevention (2024-2032) ($MN)
- Table 26 Global Companion Animal Genomics & DNA Testing Market Outlook, By Personalized Treatment Planning (2024-2032) ($MN)
- Table 27 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeding Management (2024-2032) ($MN)
- Table 28 Global Companion Animal Genomics & DNA Testing Market Outlook, By Behavioral & Trait Analysis (2024-2032) ($MN)
- Table 29 Global Companion Animal Genomics & DNA Testing Market Outlook, By End User (2024-2032) ($MN)
- Table 30 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Clinics & Hospitals (2024-2032) ($MN)
- Table 31 Global Companion Animal Genomics & DNA Testing Market Outlook, By Pet Owners (2024-2032) ($MN)
- Table 32 Global Companion Animal Genomics & DNA Testing Market Outlook, By Research Institutions (2024-2032) ($MN)
- Table 33 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeders & Kennel Clubs (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
